Cannabis and Mental Illness (1 CE)
This course is for: Clinical Psychologists, Counselors, and LMFTs
Course By: Tamara Avery, PsyD
Content By: Lowe, D., Sasiadek, J.D., Coles, A.S., George, T.P. (2019). Cannabis and mental illness: a review. University of Toronto, European Archives of Psychiatry and Clinical Neuroscience 269(1): 107–120.
Course Description: The legalization of cannabis in Western nations leaves vulnerable populations open to the potential impact of policy changes. Specifically, those with mental illnesses including schizophrenia, mood and anxiety disorders are determined to have strong motives to seek short-term reward (e.g., “getting high”). Though data has increasingly been shown to support the harmful effects of cannabis in patients with psychotic and mood disorders, little research has been conducted on the beneficial effect’s cannabis use may have on this population. Additional hypotheses were used in developing a framework for assessment and treatment of problematic cannabis use in mentally ill users.
- Review the concept of harmful effects versus the potential benefits cannabis has on mental illness
- Review the framework for assessment and treatment of problematic cannabis use in patients with mental illness
- Consider the statistical findings and the directions for future research
- Read Cannabis and Mental Illness: A Review
- Review the Course Description and Learning Objectives
- Consider the effects of cannabis in patients with mental illness
- Complete the post-test questions. Remember all answers should be derived from the accompanying article
- Return to the referenced article for missed questions and/or to understand the role cannabis use has on mental health
|Board Approvals||American Psychological Association (APA), NBCC, Florida Board - Social Work, MFT, Counseling, and Psychology, NYSED - Social Work, MFT and Counseling Only, American Academy of Health Care Providers in the Addictive Disorders|
|CE Format||Online, Text-Based|